Teijin Pharma, the core company of the Teijin Group’s healthcare business, has elected Akihisa Nabeshima as President
Nabeshima is currently corporate officer of the Teijin Group and Senior Executive Director of Teijin Pharma, as its next president.
Nabeshima will assume his new role on April 1. Hiroshi Uno, the current President, will assume the post of responsible for healthcare business of the Teijin Limited.
Teijin is a technology-driven global group offering advanced solutions in the areas of sustainable transportation, information and electronics, safety and protection, environment and energy, and healthcare.
Its main fields of operation are high-performance fibers such as aramid, carbon fibers and composites, healthcare, films, resin and plastic processing, polyester fibers, products converting and IT.
The group has some 150 companies and around 16,000 employees spread out over 20 countries worldwide. It posted consolidated sales of around $7.4 bn and total assets of around $7.7 bn in the fiscal year ending March 31, 2016.www.teijin.com